ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Discovery of LH10, a novel fexaramine-based FXR agonist for the treatment of liver disease

Huang, Wanqiu; Cao, Zhijun; Wang, Wenxin; Yang, Zhongcheng; Jiao, Shixuan; Chen, Ya; Chen, Siliang; Zhang, Luyong*; Li, Zheng*广东药学院
Bioorganic Chemistry2024-2DOI: 10.1016/j.bioorg.2023.107071
13阅读
引用收藏
分享

摘要

Farnesoid X receptor (FXR) was considered as a promising drug target in the treatment of cholestasis, druginduced liver injury, and non-alcoholic steatohepatitis (NASH). However, the existing FXR agonists have shown different degrees of side effects in clinical trials without clear interpretation. MET-409 in clinical phase III, has been proven significantly fewer side effects than that of other FXR agonists. This may be due to the completely different structure of FEX and other non-steroidal FXR agonists. Herein, the structure-based drug design was carried out based on FEX, and the more active FXR agonist LH10 (FEX EC50 = 0,3 mu M; LH10 EC50 = 0.14 mu M)) was screened out by the comprehensive SAR studies. Furthermore, LH10 exhibited robust hepatoprotective activity on the ANIT-induced cholestatic model and APAP-induced acute liver injury model, which was even better than positive control OCA. In the nonalcoholic steatohepatitis (NASH) model, LH10 significantly improved the pathological characteristics of NASH by regulating several major pathways including lipid metabolism, inflammation, oxidative stress, and fibrosis. With the above attractive results, LH10 is worthy of further evaluation as a novel agent for the treatment of liver disorders.

学科与关键词

关键词
FXRNAFLDCholestatic liver diseaseDILI
相关
加载中…
  • Discovery of a tricyclic farnesoid X receptor agonist HEC96719, a clinical candidate for treatment of non-alcoholic steatohepatitis
    Cao, Shengtian; Yang, Xinye; Zhang, Zheng; Wu, Junwen; Chi, Bo; Chen, Hong; Yu, Jianghong; Feng, Shanshan; Xu, Yulin; Li, Jing; Zhang, Yingjun; Wang, Xiaojun*; Wang, Yan*European Journal of Medicinal Chemistry, 2022, 230: 114089.被引 9
  • Design, synthesis, and biological studies of novel sulfonamide derivatives as farnesoid X receptor agonists
    Wang, Wenxin; Cao, Zhijun; Yang, Zhongcheng; Chen, Ya; Yao, Huixin; Zhou, Danting; Ou, Peixin; Huang, Wanqiu; Jiao, Shixuan; Chen, Siliang; Chen, Lianru; Liu, Yuxia; Mao, Jianming; Xie, Jiayi; Xiang, Ruojing; Yang, Yuanqian; Chen, Yisi; Yang, Yonghong; Tan, Liyun; Tang, Haolong; Zhang, Luyong*; Li, Zheng*European Journal of Medicinal Chemistry, 2023, 258: 115614.
  • Discovery of a novel and orally active Farnesoid X receptor agonist for the protection of acetaminophen-induced hepatotoxicity
    Cai, Zongyu; Wang, Bin; Zhou, Zongtao; Zhao, Xin; Hu, Lijun; Ren, Qiang; Deng, Liming; Li, Zheng*; Wang, Guangji*Chemical Biology and Drug Design, 2022, 99(3): 483-495.被引 3
查看全部 →

发表信息

论文状态
公开发表
期刊
Bioorganic Chemistry
发表日期
2024-02
卷期
第 143 卷
页码
107071
DOI
10.1016/j.bioorg.2023.107071
语言
ENGLISH
成果收录
SCIE
资助标注
Basic and Applied Basic Research of Guangzhou [202201010436]; National Key Clinical Specialty Construction Project (Clinical Pharmacy); High-Level Clinical Key Specialty (Clinical Pharmacy) in Guangdong Province, Guangdong Provincial Key Laboratory of Construction Foundation [2020B1212060034]; Beijing Key Laboratory of Metabolic Disorder Related Cardiovascular Disease [DXWL-202304]

作者

  • H

    Huang, Wanqiu (第一作者)

    guangdong pharmaceut univ · new

  • C

    Cao, Zhijun

    guangdong pharmaceut univ · new

查看全部 9 位作者收起作者
  • W

    Wang, Wenxin

    guangdong pharmaceut univ

  • Y

    Yang, Zhongcheng

    guangdong pharmaceut univ

  • J

    Jiao, Shixuan

    guangdong pharmaceut univ

  • C

    Chen, Ya

    guangdong pharmaceut univ

  • C

    Chen, Siliang

    guangdong pharmaceut univ

  • Z

    Zhang, Luyong (通讯)

    guangdong pharmaceut univ · new

  • L

    Li, Zheng (通讯)

    new · guangdong pharmaceut univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417